Noninvasive surveillance with multitarget stool DNA testing or fecal immunochemical testing (FIT) could potentially match colonoscopy for reducing long-term colorectal cancer (CRC) incidence and ...

Tracing the cause of the infection can be a laborious process.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

WESTBROOK, Maine, Jan. 12, 2024 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announced the expansion of its Fecal Dx® antigen testing platform ...

Fecal testing is typically more popular than having a colonoscopy as the initial step in colorectal cancer screening because it can be done at home and mailed to a laboratory. However, for those with ...

IDEXX Laboratories, Inc. IDXX recently expanded its Fecal Dx antigen testing platform with the addition of Cystoisospora — a common intestinal parasite that is the source of diarrhea, weight loss and ...

Routine screening with fecal occult blood testing (FOBT) is associated with a decrease in colorectal cancer (CRC) mortality, according to a study published online Feb. 27 in JAMA Network Open.

Cyclospora now has over 1000 cases in the metro Detroit area. Symptoms include nausea, vomiting, fatigue, and explosive ...

Several at-home options for colon cancer screening are available. If any of these tests are positive, a doctor will recommend a colonoscopy for further analysis. The U.S. Preventive Services Task ...

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the expansion of its Fecal Dx™ antigen testing platform with ...